Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | multiple endocrine neoplasia I | No references | |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | pteridine reductase 1 | 0.0025 | 0.0143 | 0.5 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.0366 | 0.2613 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0026 | 0.0051 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0025 | 0.0143 | 0.1418 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.1387 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | replicative DNA helicase | 0.0723 | 0.5191 | 1 |
Schistosoma mansoni | 3-oxoacyl-[ACP] reductase | 0.0025 | 0.0143 | 0.0276 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0025 | 0.0143 | 0.5 |
Onchocerca volvulus | 0.0035 | 0.0215 | 1 | |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein reductase | 0.0025 | 0.0143 | 0.0117 |
Schistosoma mansoni | hypothetical protein | 0.0111 | 0.0765 | 0.1474 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0042 | 0.0015 |
Loa Loa (eye worm) | retinol dehydrogenase 12 | 0.0025 | 0.0143 | 0.0719 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0229 | 0.0203 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0229 | 0.0442 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.0366 | 0.2613 | 1 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0111 | 0.0765 | 0.5111 |
Loa Loa (eye worm) | oxidoreductase | 0.0025 | 0.0143 | 0.0719 |
Trichomonas vaginalis | hypothetical protein | 0.0366 | 0.2613 | 1 |
Leishmania major | 3-oxoacyl-ACP reductase, putative | 0.0025 | 0.0143 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 0.3537 | 0.6814 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0215 | 0.0414 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0025 | 0.0143 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0143 | 0.0719 |
Schistosoma mansoni | hypothetical protein | 0.0111 | 0.0765 | 0.1474 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0111 | 0.0765 | 0.1474 |
Chlamydia trachomatis | replicative DNA helicase | 0.0723 | 0.5191 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 0.3537 | 0.352 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.0366 | 0.2613 | 0.4892 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0025 | 0.0143 | 0.5 |
Leishmania major | pteridine reductase 1 | 0.0025 | 0.0143 | 0.5 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0215 | 0.2405 |
Schistosoma mansoni | Replicative DNA helicase | 0.0723 | 0.5191 | 1 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.0366 | 0.2613 | 1 |
Entamoeba histolytica | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0025 | 0.0143 | 0.5 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0025 | 0.0143 | 0.1418 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0111 | 0.0765 | 0.0741 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.0366 | 0.2613 | 0.4892 |
Loa Loa (eye worm) | twinkle helicase | 0.0206 | 0.1458 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.0439 | 0.1199 |
Chlamydia trachomatis | enoyl-acyl-carrier protein reductase | 0.0366 | 0.2613 | 0.4892 |
Schistosoma mansoni | hypothetical protein | 0.0111 | 0.0765 | 0.1474 |
Schistosoma mansoni | dihydropteridine reductase | 0.0025 | 0.0143 | 0.0276 |
Echinococcus granulosus | dnaJ subfamily B | 0.0494 | 0.3537 | 0.352 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0111 | 0.0765 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0042 | 0.0015 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0025 | 0.0143 | 0.5 |
Leishmania major | oxidoreductase-like protein | 0.0025 | 0.0143 | 0.5 |
Schistosoma mansoni | apoptosis regulator bax | 0.0111 | 0.0765 | 0.1474 |
Mycobacterium tuberculosis | Probable replicative DNA helicase DnaB | 0.0723 | 0.5191 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0229 | 0.0203 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0025 | 0.0143 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0765 | 0.5111 |
Treponema pallidum | replicative DNA helicase (dnaB) | 0.0723 | 0.5191 | 0.5 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.0366 | 0.2613 | 0.4892 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0215 | 0.1224 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.0025 | 0.0143 | 0.5 |
Mycobacterium leprae | PROBABLE REPLICATIVE DNA HELICASE DNAB replicative DNA helicase | 0.0723 | 0.5191 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.0496 | 0.0956 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0111 | 0.0765 | 0.0741 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0229 | 0.0442 |
Mycobacterium ulcerans | replicative DNA helicase DnaB | 0.0723 | 0.5191 | 1 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.0366 | 0.2613 | 0.4892 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0025 | 0.0143 | 0.5 |
Echinococcus multilocularis | 3 oxoacyl acyl carrier protein reductase | 0.0025 | 0.0143 | 0.0117 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0025 | 0.0143 | 0.0719 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 80 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of activators of hexokinase domain containing I (HKDC1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493187, AID493207] | ChEMBL. | No reference |
IC50 (functional) | > 80 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) in the hexokinase 1 selectivity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493160, AID493190] | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.